A detailed history of Yu Fan transactions in Castle Biosciences Inc stock. As of the latest transaction made, Yu Fan holds 22,503 shares of CSTL stock, worth $618,382. This represents 71.62% of its overall portfolio holdings.

Number of Shares
22,503
Previous 36,747 38.76%
Holding current value
$618,382
Previous $799,000 19.77%
% of portfolio
71.62%
Previous 77.72%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.4 - $31.47 $247,845 - $448,258
-14,244 Reduced 38.76%
22,503 $641,000
Q2 2024

Aug 14, 2024

BUY
$18.84 - $24.94 $692,313 - $916,470
36,747 New
36,747 $799,000
Q4 2023

Feb 14, 2024

BUY
$12.19 - $22.43 $274,311 - $504,742
22,503 New
22,503 $485,000
Q2 2022

Aug 15, 2022

BUY
$16.0 - $45.99 $329,472 - $947,026
20,592 New
20,592 $452,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $723M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Yu Fan Portfolio

Follow Yu Fan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yu Fan, based on Form 13F filings with the SEC.

News

Stay updated on Yu Fan with notifications on news.